Cargando…

Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391862/ https://www.ncbi.nlm.nih.gov/pubmed/28435227 http://dx.doi.org/10.2147/DDDT.S130751

Ejemplares similares

Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
por: Zhou, X, et al.
Publicado: (2015)

Relaxin inhibits renal fibrosis and the epithelial-to-mesenchymal transition via the Wnt/β-catenin signaling pathway
por: Feiteng, Chen, et al.
Publicado: (2022)

Corrigendum: H3 relaxin inhibits the collagen synthesis via ROS‐ and P2X7R‐mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose
por: Yin, Xinhua
Publicado: (2018)

Corrigendum to “The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways”
por: Liang, Shufang, et al.
Publicado: (2022)

Corrigendum to “Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction”
por: Tasanarong, Adis, et al.
Publicado: (2017)

Corrigendum to: Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
Publicado: (2022)

[Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway
por: Kou, Bo, et al.
Publicado: (2023)

Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling
por: Sassoli, Chiara, et al.
Publicado: (2013)

Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway [Corrigendum]
por: Mu, Mao, et al.
Publicado: (2019)

miR-146a-5p mediates epithelial–mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2
por: Wang, Cong, et al.
Publicado: (2018)

Corrigendum to: Adiponectin Inhibits Lipopolysaccharide-Induced Adventitial Fibroblast Migration and Transition to Myofibroblasts via AdipoR1-AMPK-iNOS Pathway
Publicado: (2022)

Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
por: Bu, Wenhuan, et al.
Publicado: (2019)

Disulfiram Inhibits Epithelial–Mesenchymal Transition Through TGFβ–ERK–Snail Pathway Independently of Smad4 to Decrease Oral Squamous Cell Carcinoma Metastasis [Corrigendum]
Publicado: (2021)

Curcumin Protects Against Myocardial Infarction-Induced Cardiac Fibrosis via SIRT1 Activation in vivo and in vitro [Corrigendum]
Publicado: (2022)

miR-26b inhibits isoproterenol-induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway
por: Xiang, Shaohua, et al.
Publicado: (2020)

Interplay between BMP2 and Notch signaling in endothelial-mesenchymal transition: implications for cardiac fibrosis
por: Docshin, Pavel, et al.
Publicado: (2023)

High glucose promotes hepatic fibrosis via miR-32/MTA3-mediated epithelial-to-mesenchymal transition
por: Li, Qiang, et al.
Publicado: (2022)

[Corrigendum] Downregulation of Notch1 induces apoptosis and inhibits cell proliferation and metastasis in laryngeal squamous cell carcinoma
por: Dai, Meng-Yuan, et al.
Publicado: (2023)

Corrigendum to “TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice” [EBioMedicine (2018) 54–62]
por: Wang, Zhen, et al.
Publicado: (2018)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial-mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2022)

[Corrigendum] MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: Wang, Shengjie, et al.
Publicado: (2023)

Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2022)

Corrigendum to “β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats”
por: Cuevas, Catherina A., et al.
Publicado: (2016)

Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1
por: Wilhelmi, Tim, et al.
Publicado: (2020)

[Corrigendum] Epigallocatechin‑3‑gallate inhibits nicotine‑induced migration and invasion by the suppression of angiogenesis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells
por: Shi, Jingli, et al.
Publicado: (2023)

LncRNA LOC105372579 promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma via activating miR-4316/FOXP4 signaling [Corrigendum]
Publicado: (2019)

[Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells
por: Liu, Zhiqi, et al.
Publicado: (2023)

Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway
por: Yao, Jiamei, et al.
Publicado: (2022)

MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial–mesenchymal transition in lung cancer cells [Corrigendum]
Publicado: (2018)

Corrigendum to “Mesenchymal Stem Cells Attenuate Radiation-Induced Brain Injury by Inhibiting Microglia Pyroptosis”
por: Liao, Huan, et al.
Publicado: (2018)

Telocinobufagin inhibits the epithelial-to-mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway
por: Gao, Yuxue, et al.
Publicado: (2021)

Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis
por: Liu, Xiaoqiang, et al.
Publicado: (2023)

Relaxin ameliorates high glucose-induced cardiomyocyte hypertrophy and apoptosis via the Notch1 pathway
por: Wei, Xiao, et al.
Publicado: (2018)

[Corrigendum] Mesenchymal stem cells expressing interleukin‑18 inhibit breast cancer in a mouse model
por: Liu, Xiaoyi, et al.
Publicado: (2023)

Expression and association of VEGF-Notch pathways in infantile hemangiomas
por: Li, Shangbin, et al.
Publicado: (2018)

Corrigendum to “NONHSAT098487.2 protects cardiomyocytes from oxidative stress injury by regulating the Notch pathway” [Heliyon 9(6) (June 2023) e17388]
por: Feng, Guiju, et al.
Publicado: (2023)

Corrigendum to “Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury”
por: Suchal, Kapil, et al.
Publicado: (2020)

Corrigendum to “The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes”
por: Napoli, Nicola, et al.
Publicado: (2017)

lncRNA-CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway
por: Wang, Hongqi, et al.
Publicado: (2022)

Corrigendum to “miR-1-Mediated Induction of Cardiogenesis in Mesenchymal Stem Cells via Downregulation of Hes-1”
por: Huang, Feng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mjrjl76qsofiu1ubvtno71i904